Published by Coherent Market Insights
Posted on September 29, 2021
The Direct-to-Consumer Genetic Testing Devices Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Direct-to-Consumer Genetic Testing Devices Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Key players in the Direct-to-Consumer Genetic Testing Devices market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customer’s requirements.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1046
Direct to Consumer genetic testing devices are used in the process of analyzing a person’s genetic material, their metabolic processes, and their ancestry by an independent laboratory for a charge. These tests are used for many reasons by many different organizations. Some of these reasons are to determine if a person has an inherited medical condition like sickle-cell anemia; to find out whether or not they are at risk of certain diseases such as diabetes and heart disease; and to look for health-related problems, like breast cancer, that might develop in the future. Some of the diseases or conditions that can be detected through genetic testing are Down syndrome, Fragile X Syndrome, Turner Syndrome, and Huntington’s disease.
Key Market Drivers:
The increasing cases of genetic disorders in the world are the main factor that is expected to augment the growth of the global direct-to-consumer genetic testing devices market. For instance, according to the U.S. National Institutes of Health (NIH), there are more than 6000 known genetic disorders in the world. Over 600 of these disorders are in the treatable category, and approximately 1 in 50 individuals suffer from single-gene disorders and approximately 1 in 263 suffer from chromosomal issues. Some companies offer direct-to-consumer genetic testing services that utilize DNA banks or specialized hardware called genomics chips. The results from this type of test are usually faster and more accurate than the test that is send into the lab. For example, if someone sent in a swab of their DNA for testing to an ancestry testing company they would most likely get a response within seven days. The results may still come in later in the week if the results sample isn’t ready yet. However, if the DNA is tested directly on the computer screen with the help of a genomics tool, it will typically return the results within 24 hours.
Covid-19 Impact Analysis:
The COVID-19 pandemic has changed the whole scenario of global healthcare, which also impacted the global direct-to-consumer genetic testing devices market. For instance, the U.S. National Institutes of Health (NIH), several types of research have found that over 10% of the individuals developing severe COVID-19 have misguided autoantibodies, which attack the human immune system, instead of the virus which causes the issues. Around 3.5% or more of individuals who were tested positive COVID-19 were diagnosed with a very specific kind of genetic issue, which impacts immunity.
Key Takeaways:
The size of the global direct-to-consumer genetic testing devices market was estimated at around US$ 1 billion in 2019, and a CAGR of 12.8% is projected to increase between 2020 and 2028, owing to the increasing prevalence of genetic disorders in the world. For instance, according to the U.S. National Institutes of Health (NIH), around 10% of adults in the world are suffering from genetic disorders.
North America is expected to hold a major share of the global direct-to-consumer genetic testing devices market, owing to the increasing investments in genetic studies in the region. For instance, according to The Conversation, the US invests around US$ 3 billion every year in genetic researches.
The Asia Pacific is estimated to witness high growth in the global direct-to-consumer genetic testing devices market, owing to the increasing prevalence of genetic disorders in the region. For instance, according to the Indian Genetic Disease Database (IGDD), there are around 52 genetic issues prevalent in the Indian population.
What Direct-to-Consumer Genetic Testing Devices Market report offers:
Major Players Analysed The Market
These Players Are: 23andMe, Pathway Genomics, Color Genomics, Counsyl, Inc., deCode genetics, Inc., Map My Gene, and GenePartner.
Remarkable Attributes of Direct-to-Consumer Genetic Testing Devices Market Report:
Buy This Research Study Report For Quick Access with flat US $ 2000 off@ https://www.coherentmarketinsights.com/promo/buynow/1046
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
The post Covid-19 Impact Analysis on Direct-to-Consumer Genetic Testing Devices Market with Future Business Opportunities and Top Competitor Analysis appeared first on Gatorledger.
The Direct-to-Consumer Genetic Testing Devices Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Direct-to-Consumer Genetic Testing Devices Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Key players in the Direct-to-Consumer Genetic Testing Devices market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customer’s requirements.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1046
Direct to Consumer genetic testing devices are used in the process of analyzing a person’s genetic material, their metabolic processes, and their ancestry by an independent laboratory for a charge. These tests are used for many reasons by many different organizations. Some of these reasons are to determine if a person has an inherited medical condition like sickle-cell anemia; to find out whether or not they are at risk of certain diseases such as diabetes and heart disease; and to look for health-related problems, like breast cancer, that might develop in the future. Some of the diseases or conditions that can be detected through genetic testing are Down syndrome, Fragile X Syndrome, Turner Syndrome, and Huntington’s disease.
Key Market Drivers:
The increasing cases of genetic disorders in the world are the main factor that is expected to augment the growth of the global direct-to-consumer genetic testing devices market. For instance, according to the U.S. National Institutes of Health (NIH), there are more than 6000 known genetic disorders in the world. Over 600 of these disorders are in the treatable category, and approximately 1 in 50 individuals suffer from single-gene disorders and approximately 1 in 263 suffer from chromosomal issues. Some companies offer direct-to-consumer genetic testing services that utilize DNA banks or specialized hardware called genomics chips. The results from this type of test are usually faster and more accurate than the test that is send into the lab. For example, if someone sent in a swab of their DNA for testing to an ancestry testing company they would most likely get a response within seven days. The results may still come in later in the week if the results sample isn’t ready yet. However, if the DNA is tested directly on the computer screen with the help of a genomics tool, it will typically return the results within 24 hours.
Covid-19 Impact Analysis:
The COVID-19 pandemic has changed the whole scenario of global healthcare, which also impacted the global direct-to-consumer genetic testing devices market. For instance, the U.S. National Institutes of Health (NIH), several types of research have found that over 10% of the individuals developing severe COVID-19 have misguided autoantibodies, which attack the human immune system, instead of the virus which causes the issues. Around 3.5% or more of individuals who were tested positive COVID-19 were diagnosed with a very specific kind of genetic issue, which impacts immunity.
Key Takeaways:
The size of the global direct-to-consumer genetic testing devices market was estimated at around US$ 1 billion in 2019, and a CAGR of 12.8% is projected to increase between 2020 and 2028, owing to the increasing prevalence of genetic disorders in the world. For instance, according to the U.S. National Institutes of Health (NIH), around 10% of adults in the world are suffering from genetic disorders.
North America is expected to hold a major share of the global direct-to-consumer genetic testing devices market, owing to the increasing investments in genetic studies in the region. For instance, according to The Conversation, the US invests around US$ 3 billion every year in genetic researches.
The Asia Pacific is estimated to witness high growth in the global direct-to-consumer genetic testing devices market, owing to the increasing prevalence of genetic disorders in the region. For instance, according to the Indian Genetic Disease Database (IGDD), there are around 52 genetic issues prevalent in the Indian population.
What Direct-to-Consumer Genetic Testing Devices Market report offers:
Major Players Analysed The Market
These Players Are: 23andMe, Pathway Genomics, Color Genomics, Counsyl, Inc., deCode genetics, Inc., Map My Gene, and GenePartner.
Remarkable Attributes of Direct-to-Consumer Genetic Testing Devices Market Report:
Buy This Research Study Report For Quick Access with flat US $ 2000 off@ https://www.coherentmarketinsights.com/promo/buynow/1046
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
The post Covid-19 Impact Analysis on Direct-to-Consumer Genetic Testing Devices Market with Future Business Opportunities and Top Competitor Analysis appeared first on Gatorledger.
Explore more articles in the Research Reports category
